156 results
Page 2 of 8
8-K
4mnlei3txsd
3 Aug 23
MyMD Pharmaceuticals Phase 2 Trial Update
4:30pm
8-K
ljae0u3jnmiwsqh4qv4w
31 Jul 23
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline
9:00am
DEFA14A
4r3u8karej0cemvyjzd
21 Jul 23
Additional proxy soliciting materials
4:30pm
8-K
eykahfgjj4iphprjh5rz
9 Jun 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:30pm
8-K
vp7qweeuppb
12 Apr 23
Regulation FD Disclosure
8:45am
8-K
4ko935u2m
8 Dec 22
MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022
4:15pm
8-K
w7np9eh
18 Nov 22
MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress
4:30pm
8-K
4641fvkcurg26ay21yti
14 Nov 22
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Data Research
8:32am
DEFA14A
7njzfwk2ds k9c
26 Oct 22
Additional proxy soliciting materials
5:19pm
8-K
p62gen yh
20 Sep 22
Efficacy data anticipated in Q4 of 2022
8:00am
8-K
phkofvqpbbsu7vkwjr
31 Aug 22
Mymd Pharmaceuticals Receives Grant from European
8:00am
D
90hk cwo3ob
30 Aug 22
$7.41M in options / securities to be acquired, 8 investors
8:00am
8-K
crr8 cf1ie
3 Aug 22
Regulation FD Disclosure
4:30pm
8-K
orswp39
26 Jul 22
Regulation FD Disclosure
4:30pm
8-K
o3mchz8x4ny349y
12 Jul 22
Bascom Palmer Eye Institute ranked the #1 eye hospital in the United States for 20 years in a row by U.S. News & World Report
4:05pm